Clinical Trials Directory

Trials / Completed

CompletedNCT04961281

Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome

Dexmedetomidine Versus Triamcinolone Local Injection for Pain Alleviation in Patients With Carpal Tunnel Syndrome; A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modaleties are available for treatment of mild to moderate CTS.

Detailed description

Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modaleties are available for treatment of mild to moderate CTS. In case of failed conservative oral therapey, local hydro-dessction of the median nerve can be done with saline alone. local anethetics, steroids, hyalase,and ozone have been utilized to augment the symptoms reliefe. Dexmeditomidine (DEX) has been studied as adjuvant for nerve block to aumnet the pain reliefe. Recently, it has been discovered that DEX can offer some antinflammatory effects when injected in the perineural area. Upon such discovery, the goal of this study has been built.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineinjection of Dexmedetomidine ( 10 microgram/kg) + 10 cc saline injection nearby median nerve as hydro-dissection
DRUGTriamcinoloneinjection of triamcinolone ( 40 mg) + 10 cc saline injection nearby median nerve as hydro-dissection

Timeline

Start date
2021-07-22
Primary completion
2022-07-31
Completion
2022-08-01
First posted
2021-07-14
Last updated
2022-11-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04961281. Inclusion in this directory is not an endorsement.